Victory Capital Management
CVS icon

Victory Capital Management’s CVS Health CVS Stock Holding History

Victory Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144M Sell
1,390,052
-270,470
-16% -$24.1M 0.08% 253
2026
Q1 		$119M Buy
1,660,522
+84,157
+5% +$6.48M 0.08% 268
2025
Q4 		$125M Buy
1,576,365
+212,162
+16% +$16.7M 0.07% 262
2025
Q3 		$103M Buy
1,364,203
+53,048
+4% +$3.64M 0.06% 293
2025
Q2 		$90.4M Buy
1,311,155
+290,603
+28% +$19.1M 0.06% 336
2025
Q1 		$69.1M Sell
1,020,552
-40,583
-4% -$2.43M 0.07% 339
2024
Q4 		$47.6M Sell
1,061,135
-141,190
-12% -$7.92M 0.05% 474
2024
Q3 		$75.6M Sell
1,202,325
-291,212
-19% -$17M 0.07% 322
2024
Q2 		$88.2M Sell
1,493,537
-233,924
-14% -$14.6M 0.09% 271
2024
Q1 		$138M Buy
1,727,461
+138,177
+9% +$10.6M 0.13% 167
2023
Q4 		$125M Sell
1,589,284
-81,312
-5% -$5.79M 0.13% 177
2023
Q3 		$117M Buy
1,670,596
+479,643
+40% +$34M 0.13% 173
2023
Q2 		$82.3M Buy
1,190,953
+114,735
+11% +$8.16M 0.09% 278
2023
Q1 		$80M Sell
1,076,218
-64,264
-6% -$5.39M 0.09% 292
2022
Q4 		$106M Sell
1,140,482
-60,409
-5% -$5.83M 0.12% 206
2022
Q3 		$115M Buy
1,200,891
+92,991
+8% +$9.2M 0.13% 186
2022
Q2 		$103M Sell
1,107,900
-18,547
-2% -$1.81M 0.12% 222
2022
Q1 		$110M Sell
1,126,447
-22,866
-2% -$2.4M 0.11% 233
2021
Q4 		$119M Sell
1,149,313
-108,856
-9% -$10.1M 0.11% 229
2021
Q3 		$107M Buy
1,258,169
+5,892
+0.5% +$494K 0.1% 248
2021
Q2 		$104M Buy
1,252,277
+54,295
+5% +$4.45M 0.1% 255
2021
Q1 		$90.1M Buy
1,197,982
+180,997
+18% +$13.2M 0.09% 297
2020
Q4 		$69.5M Buy
1,016,985
+53,516
+6% +$3.48M 0.08% 393
2020
Q3 		$56.3M Buy
963,469
+175,079
+22% +$10.9M 0.07% 425
2020
Q2 		$51.2M Sell
788,390
-1,539,114
-66% -$96.9M 0.07% 417
2020
Q1 		$138M Buy
2,327,504
+1,043,348
+81% +$69.7M 0.12% 250
2019
Q4 		$95.4M Sell
1,284,156
-106,661
-8% -$7.49M 0.12% 243
2019
Q3 		$87.7M Buy
1,390,817
+1,082,955
+352% +$64.2M 0.11% 254
2019
Q2 		$16.8M Sell
307,862
-148,276
-33% -$7.98M 0.03% 660
2019
Q1 		$24.6M Sell
456,138
-373,502
-45% -$23.1M 0.06% 514
2018
Q4 		$54.4M Sell
829,640
-82,945
-9% -$6.19M 0.14% 211
2018
Q3 		$71.8M Sell
912,585
-105,897
-10% -$7.57M 0.15% 192
2018
Q2 		$65.5M Buy
1,018,482
+619,702
+155% +$40.8M 0.14% 206
2018
Q1 		$24.8M Buy
398,780
+114,022
+40% +$8.18M 0.05% 536
2017
Q4 		$20.6M Sell
284,758
-157,570
-36% -$11.5M 0.04% 568
2017
Q3 		$36M Buy
442,328
+57,424
+15% +$4.54M 0.08% 397
2017
Q2 		$31M Sell
384,904
-123,355
-24% -$9.74M 0.07% 448
2017
Q1 		$39.9M Sell
508,259
-260,494
-34% -$20.8M 0.1% 356
2016
Q4 		$60.7M Sell
768,753
-714,584
-48% -$57.8M 0.15% 230
2016
Q3 		$132M Buy
1,483,337
+823,462
+125% +$77.7M 0.37% 30
2016
Q2 		$63.2M Sell
659,875
-10,371
-2% -$1.03M 0.25% 131
2016
Q1 		$69.5M Sell
670,246
-223,516
-25% -$21.7M 0.29% 101
2015
Q4 		$87.4M Buy
893,762
+18,955
+2% +$1.86M 0.36% 66
2015
Q3 		$84.4M Sell
874,807
-102,432
-10% -$10.8M 0.35% 75
2015
Q2 		$102M Sell
977,239
-193,435
-17% -$19.8M 0.38% 63
2015
Q1 		$121M Sell
1,170,674
-372,294
-24% -$37.7M 0.43% 48
2014
Q4 		$149M Buy
1,542,968
+366,590
+31% +$32.3M 0.55% 21
2014
Q3 		$93.6M Buy
1,176,378
+8,737
+0.7% +$689K 0.71% 25
2014
Q2 		$87.7M Buy
1,167,641
+537,483
+85% +$40.6M 0.59% 30
2014
Q1 		$47.2M Buy
+630,158
New +$44.5M 0.32% 108
2013
Q4 		– Sell
-349
Closed -$19K – 955
2013
Q3 		$19K Buy
+349
New +$20.8K ﹤0.01% 948

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Victory Capital Management's CVS Position: Q2 2026 in Review

Victory Capital Management reduced its CVS Health (CVS) stake by 16% in Q2 2026, selling an estimated $24.1M and leaving 1,390,052 shares worth $144M. The position accounts for 0.08% of the portfolio, ranked #253.

Victory Capital Management first reported a position in CVS in Q3 2013 and has held it in 51 quarters since. The position peaked at $149M in Q4 2014. 1,770 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Victory Capital Management held 1,390,052 shares of CVS Health worth $144M as of Q2 2026.
  • Victory Capital Management sold 270,470 CVS Health shares in Q2 2026, an estimated $24.1M.
  • CVS Health made up 0.08% of Victory Capital Management's portfolio in Q2 2026, its #253 holding.
  • Victory Capital Management first reported a position in CVS Health in Q3 2013 and has held it in 51 quarters since.
  • Victory Capital Management's CVS Health position peaked at $149M in Q4 2014.
  • 1,770 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.